What is the risk of depression relapse in patients who discontinue liothyronine treatment?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18195434
Cited by: 0

Abstract

There is limited direct evidence on the risk of depression relapse following the discontinuation of liothyronine, though general medical understanding suggests a potential risk due to its role in mood stabilization.

Fields of Study & Subjects

Stress Responses and Cortisol Suicide and Self-Harm Studies Sexual function and dysfunction studies

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
9 January 2026